Table 6.
Level III lymph node involvement and various pathological markers with tumor grade
| PNI | Level III ALN | ||
| Total | Positive | Negative | |
| Positive | 25 | 23 (92%) | 2 (8%) |
| Negative | 45 | 24 (53.3%) | 21 (46.7%) |
| LVI | Level III ALN | ||
| Total | Positive | Negative | |
| Positive | 45 | 40 (88.9%) | 5 (11.1%) |
| Negative | 25 | 7 (28%) | 18 (72%) |
| ECE | Level III ALN | ||
| Total | Positive | Negative | |
| Positive | 24 | 21 (87.5%) | 3 (12.5%) |
| Negative | 46 | 26 (56.5%) | 20 (43.5%) |
| HER2 | Level III ALN | ||
| Total | Positive | Total | |
| Positive | 25 | Positive | 25 |
| Negative | 45 | Negative | 45 |
| ER | Level III ALN | ||
| Total | Positive | Negative | |
| Positive | 43 | 29 (67.4%) | 14 (32.6%) |
| Negative | 27 | 18 (66.7%) | 9 (33.3%) |
| PR | Level III ALN | ||
| Total | Positive | Negative | |
| Positive | 25 | 21 (84%) | 4 (16%) |
| Negative | 45 | 26 (57.8%) | 19 (42.2%) |
| Tumor grade | Level III ALN | ||
| Total | Positive | Total | |
| Grade 1 or 2 | 45 | Grade 1 or 2 | 45 |
| Grade 3 | 25 | Grade 3 | 25 |